TP53 mutations and azacitidine treatment: to be or not to be related?
Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Italy. Electronic address: rglgmt@unife.it.
Gian Matteo
GM
Rigolin
Hematology Section, Azienda Ospedaliero Universitaria Arcispedale S. Anna, University of Ferrara, Italy.
Antonio
A
Cuneo
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D016158:Genes, p53; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics*
D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine